Go
View All
Diagnostic criteria for multiple myeloma and related plasma cell disorders
Diagnostic Workup
Diagram highlighting the location of tumors to be staged as distal bile duct tumors
Differences in defining criteria between the 7th Edition and the 8th Edition for staging of NPC: (A) changing the extent of soft tissue involvement as T2 and T4 criteria
Differences in prognostication of overall survival between the 7th Edition (Left) and the 8th Edition (Right) by (A) T-category, (B) N-category, and (C) stage group for NPC
Differential lymphatic drainage patterns for left and right liver intrahepatic cholangiocarcinomas
Direct thrombin inhibitors (DTI)
Disease progression in gastric GISTs
Disease progression in small intestinal GISTs
Disease-specific survival: all patients, MSKCC data, 8th Edition
Disease-specific survival: all patients 55 years old, MSKCC data, 8th Edition
Disease-specific survival: patients <55 years old, MSKCC data, 8th Edition
Disease-specific survival comparing AJCC 7th Edition G3T2N0M0 primary STS to GXTXN1M0 and GXTXN1M1 STS, n = 1440 total; G3T2N0M0 disease (n = 1123), GXTXN1M0 (n = 33), GXTXN1M1 (n = 15), and GXTXN0M1 disease (n = 269); log rank, p < 0
Disseminated peritoneal adenomucinosis (DPAM)
Disseminated tumor cells (DTCs)
Distal Bile Duct
Distal extension to duodenum does not affect the T3 category
Distant metastasis (M)
Distribution of mutations in GIST prior to treatment with systemic therapy
DMARDs
Docetaxel
Dopamine
DTI
Duodenum and ampulla of Vater
Displaying items 451 - 480 of 1114